Overview

Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.

Status:
Recruiting
Trial end date:
2021-04-05
Target enrollment:
Participant gender:
Summary
Comparison outcomes of a large cohort of moderate and severe COVID-19 patients received different Antiviral and Anti Inflammatory Drugs.
Phase:
Phase 4
Details
Lead Sponsor:
October 6 University
Collaborator:
Beni-Suef University
Treatments:
Hydroxychloroquine
Ivermectin
Lopinavir
Remdesivir
Ritonavir